News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,942 stories indexed, page 93 of 150

🌍Jun 21, 2024Industrymaravai.com

Featured signal

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

Publisher

Maravai LifeSciences

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Maravai LifeSciencesOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇺🇸Jun 21, 2024Devicesdanaher.com

California Transparency in Supply Chains Act

Danaher Company NewsOriginal source

🌍Jun 20, 2024Industrytrevena.com

Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models

TrevenaOriginal source

🌍Jun 20, 2024Mediacentogene.com

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

CentogeneOriginal source

🌍Jun 20, 2024Industryonkuretherapeutics.com

OnKure Announces the Appointment of Rogan Nunn, J.D., as General Counsel and Secretary

OnKure TherapeuticsOriginal source

🌍Jun 15, 2024Researchcu.edu.eg

Dr. Elkhosht welcomes a high-level delegation from Fudan University of China to Cairo International University (CIU)开罗大学校长Mohamed Elkhosht博士在开罗国际大学接待了由复旦大学校长金力博士率领的代表团访问。复旦大学被公认为国际排名较高的顶尖学府之一。

Cairo UniversityOriginal source

🇺🇸Jun 15, 2024CDMOadarepharmasolutions.com

From Risk To Resolution: A Breakthrough in Nitrosamine Analysis & Mitigation

Adare PharmaceuticalsOriginal source

🌍Jun 13, 2024Industrymatinasbiopharma.com

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

Matinas BioPharmaOriginal source

🌍Jun 13, 2024Researchcu.edu.eg

Dr.Elkhosht et l ambassadeur de France inaugurent le bureau national de l Agence Universitaire de la Francophonie à l Université internationale du Caire dans la ville du 6 octobre

Cairo UniversityOriginal source

🌍Jun 13, 2024Researchcu.edu.eg

Cairo University Continues Its Development Journey with the Release of the Third Sustainable Development Report

Cairo UniversityOriginal source

🇺🇸Jun 13, 2024CDMOnoramco.com

Diversifying the Supply of Raw Materials

NoramcoOriginal source

🌍Jun 7, 2024Regulatoryzamra.co.zm

ZAMRA SIGNS A MEMORUNDUM OF UNDERSTANDING WITH THE EGYPTIAN DRUG AUTHORITY (EDA)

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🇬🇧Jun 6, 2024CDMOergomedgroup.com

Enhancing Good Pharmacovigilance Practice with ADAMAS Consulting

ErgomedOriginal source

🌍Jun 5, 2024Industryabelzeta.com

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024

AbelZeta PharmaOriginal source

🌍Jun 4, 2024Mediabreakingcancernews.com

From Humble Beginnings to A-List Cancer Fighter: Paige’s Remarkable Journey

PaigeOriginal source

🌍May 31, 2024Mediacentogene.com

CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting

CentogeneOriginal source

🇮🇱May 30, 2024Devicesmedinol.com

CE Approval for Medinol’s EluNIR-PERL™ Drug-Eluting Stent System

MedinolOriginal source

🇨🇭May 29, 2024Industryalentis.ch

Alentis Receives FDA Orphan Drug Designation for Lixudebart to Treat Idiopathic Pulmonary Fibrosis

Alentis TherapeuticsOriginal source

🇯🇵May 27, 2024Deviceshoya.com

TCFD Disclosure updated in 2024

HOYA CorporationOriginal source

🇮🇱May 23, 2024Devicesmedinol.com

Dr. Raj Dave of Cardiovascular Experts of PA implanted the EluNIR – PERL DES

MedinolOriginal source

🇮🇱May 23, 2024Devicesmedinol.com

FDA Approves Early Feasibility Study for our Groundbreaking ChampioNIR™ Drug-Eluting Peripheral Stent System

MedinolOriginal source

🇮🇱May 23, 2024Devicesmedinol.com

Clinical considerations during spontaneous coronary artery dissection in the post-partum period: a case report

MedinolOriginal source

🌍May 21, 2024Industrycytosorbents.com

Unveiling the Impact of CytoSorb Therapy on Fluid Balance in Septic Shock Patients

CytosorbentsOriginal source

🌍May 15, 2024Industrytrevena.com

Trevena Reports First Quarter 2024 Results and Provides Business Update

TrevenaOriginal source

🌍May 15, 2024Industrymaravai.com

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center

Maravai LifeSciencesOriginal source

🇨🇭May 14, 2024Industryalentis.ch

Alentis Announces Presentations on Claudin-1 in Fibrosis at the ERA and ATS Conferences

Alentis TherapeuticsOriginal source

🌍May 13, 2024Industryonkuretherapeutics.com

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

OnKure TherapeuticsOriginal source

🇺🇸May 10, 2024Industrycapsida.com

Capsida Biotherapeutics to Present Preclinical Data for Parkinson’s Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration

Capsida BiotherapeuticsOriginal source

🇺🇸May 10, 2024Researchnews.vcu.edu

10 innovative research projects earn latest funding from VCU’s Arts, Humanities and Social Sciences Fund

VCUOriginal source

🌍May 9, 2024Industryblueprintgenetics.com

Sequencing services for Whole Genome and Whole Exome research use

Blueprint Genetics (Quest Diagnostics)Original source

🌍May 8, 2024Industrysignanthealth.com

Signant Health Boosts eCOA Leadership with Operational Innovations

Signant HealthOriginal source

🇺🇸May 7, 2024Industrycapsida.com

Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations

Capsida BiotherapeuticsOriginal source

🌍May 3, 2024Mediahealx.ai

Video: Working together to end Neurofibromatosis – speech at the CTF Patient Summit 2024

HealxOriginal source

🇺🇸May 1, 2024Industryworldwide.com

Worldwide Clinical Trials Recognized with Coveted 2024 CRO Leadership Awards Based on Customer Feedback for 11th Consecutive Year

Worldwide Clinical TrialsOriginal source

🇺🇸May 1, 2024CDMOveranex.com

Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific

VeranexOriginal source

🌍Apr 30, 2024Industrymaravai.com

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Maravai LifeSciencesOriginal source

🌍Apr 30, 2024Industryvirtualincision.com

Virtual Incision Announces Publication of Data from its U.S. Investigational Device Exemption Study in the Clinical Journal, Diseases of Colon and Rectum

Virtual IncisionOriginal source

🇬🇧Apr 24, 2024CDMOquotientsciences.com

Quotient Sciences Wins 2024 CRO Leadership Awards

Quotient SciencesOriginal source

🌍Apr 16, 2024Mediapathologynews.com

Innovative Strides in AI for Cancer Diagnosis

PaigeOriginal source

🌍Apr 15, 2024Regulatorybusinesswire.com